Yurpo, Andresa B.

HRN: 15-98-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
CEFTRIAXONE 1G (VIAL)
10/04/2025
10/11/2025
IV
2g
OD
DM Foot
Checking Initial Appropriateness 
10/04/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/04/2025
10/11/2025
IV
600mg
Q6h
DM Foot
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: